drugset / Trial / NCT03698825
TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single arm study evaluating the safety and tolerability of TEW-7197 in combination with paclitaxel in metastatic gastric cancer patients.
Timeline
- Start
- 2018-08-15
- Primary completion
- 2022-01-03
- Completion
- 2022-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vactosertib | Small molecule | 50 mg | — |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | — |